Human keratin-1.bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation

Oncogene

Volumn 16, Issue 7, 1998, Pages 853-863

  Rodríguez Villanueva, Julio ^a   Greenhalgh, David ^b   Wang, Xiao Jing ^b   Bundman, Donnie ^b   Cho, Song ^a   Delehedde, Maryse ^a   Roop, Dennis ^b   McDonnell, Timothy J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Bcl 2; Keratinocyte; Skin cancer

Indexed keywords

KERATIN; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; HUMAN; KERATINOCYTE; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; PROTO ONCOGENE; SKIN CARCINOGENESIS; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

ANIMALIA; MUS MUSCULUS;

EID: 0032545940     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201610     Document Type: Article

References (49)

1. Arbeit JM. (1996). In Skin Cancer, IM Leigh, JAN Bishop and ML Kripke, (eds), Cold Spring Harbor Laboratory Press: New York, NY, 7-34.
2. Bishop JM. (1991). Cell. 64, 235-248.
3. Brown K and Balmain A. (1995). Cancer Metast. Rev., 14, 113-124.
4. Burns PA, Kemp CJ, Gannon JV, Lane DP, Bremner R and Balmain A. (1991). Oncogene, 6, 2363-2369.
5. Chiou SK, Rao L and White E. (1994). Mol. Cell. Biol., 14, 2556-2663.
6. Clarke AP, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH. (1993). Nature (London), 362, 849-852.
7. Danno K and T. Horio T. (1987). Photochem. Photobiol., 45, 683-690.
8. Gavrieli Y, Sherman Y and Ben-Sasson SA. (1992). J. Cell Biol., 119, 493-501.
9. Greenhalgh D A, Rothnagel JA, Quintanilla MI, Orengo CC, Gagne TA, Bundman DS, Longley MA and Roop DR. (1993). Mol. Carcinog., 7, 99-110.
10. Greenhalg D A, Wang XJ, Dominey AM, Rothnagel JA and Roop DR. (1995). Skin Cancer: Mechanisms and Human Relevance H. Mukhtar (ed). CRC Press, Inc: Boca Raton, 317-330.
11. Heid HW, Moll I and Franke WW. (1988). Differentiation, 37, 137-157.
12. Hockenbery D, Zutter M, Hickey W, Nahm N and Korsmeyer SJ. (1991). Proc. Natl Acad. Sci. USA, 88, 6961-6965.
13. Johnson LD, Idler WW, Zhou XM, Roop DR and Steinert PM. (1985). Proc. Natl. Acad. Sci. USA, 82, 1896-1906.
14. Kanjilal S, Pierceall WE, Cummings KK, Kripke ML and Ananthaswamy AN. (1993). Cancer Res., 53, 2961-2964.
15. Krajewski S, Krajewska M, Shabaik A, Wang HG, Irie SF and Reed JC. (1994a). Cancer Res., 54, 5501-5507.
16. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG and Reed JC. (1994b). Am. J. Pathol., 145, 1323-1336.
17. Krajewski S, Krajewska M, and Reed JC. (1996). Cancer Res., 56., 2849-2855.
18. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T. (1993). Nature, 362, 847-849.
19. Marin MC, Hsu B, Meyn RE, Donehower LA, El-Naggar AK and McDonnell TJ. (1994). Oncogene, 9, 3107-3112.
20. Marthinuss J, Lawrence L and Seiberg M. (1995). Cell Growth Differ., 6, 239-250.
21. McDonnell TJ, Deane N, Platt FM, Nuñez G, Jaeger U, McKearn J and Korsmeyer SJ. (1989). Cell, 9, 701-710.
22. McDonnell TJ and S.J. Korsmeyer SJ. (1991). Nature, 349, 254-256.
23. Mansbridge JN and Knapp AM. (1987). J Invest. Dermatol., 89, 253-263.
24. Moll R, Franke WW, Schiller D L, Geiger B and Krepier R. (1982). Cell, 31, 11-24.
25. Nischt R, Roop DR, Mehrel T, Yuspa SH, Rentrop M, Winter H and Schweizer J. (1988). Mol. Carcinog., 1, 96-108.
26. Parker SL, Tong T, Bolden S and Wingo PA. (1996). CA Cancer J. Clin., 46, 5-27.
27. Pena JC, Fuchs E and Thompson CB. (1997). Cell Growth and Differen., 8, 619-629.
28. Pierceall WE, Goldberg LH, Tainsky MA, Mukhopadhyay T and Ananthaswamy HN. (1991). Mol. Carcinog., 4, 196-202.
29. Quintanilla M, Brown K, Ramsden M and Balmain A. (1986). Nature, (London). 32, 78-80.
30. Quilan RA, Schiller DL, Hatzfeld M, Achtstatter T, Moll R, Jorcano JL, Magin TM and Franke WW. (1985). Ann. New York Acad. Sci., 455, 282-306.
31. Rady P, Scinicariello F, Wagner RFJ and Tyring SK. (1992). Cancer Res., 52, 3804-3806.
32. Rodríguez-Villanueva J, Colome MI, Brisbay SM and McDonnell TJ. (1995). Path. Res. Pract., 191, 391-398.
33. Roop DR, Huitfeldt H, Kilkenny A and Yuspa SH. (1987). Differentiation, 35, 143-150.
34. Rosenthal DS, Steinert PM, Chung C, Huff CA, Yuspa SH and Roop DR. (1991). Cell Growth Differ 2, 107-113.
35. Rothnagel JA, Greenhalgh DA, Longley MA, Bundman D, Dominey AM and Roop DR. (1991). Cell Growth Differ., 2 107-113.
36. Rothnagel JA, Greenhalgh DA, Longley MA, Bundman D, Dominey AM and Roop DR. (1990). J. Invest. Dermatol., 94, 573.
37. Schweizer J and Winter H. (1982). Cancer Res., 42, 1517-1529.
38. Sellheyer K, Bickenbach JR, Rothnagel JA, Bundman D, Longley MA, Krieg T, Roche NS, Roberts AB and Roop DR. (1993). Proc. Natl. Acad. Sci. USA, 90, 5237-5241.
39. Seto M, Jaeger U, Hockett RD, Graninger W, Bennett S, Goldman P and Korsmeyer SJ (1988). EMBO J., 7, 123-131.
40. Shaw P, Bovey R, Tardy S, Sahli R, Sordat B and Costa J. (1992). Proc. Natl. Acad. Sci. USA, 89, 4495-4499.
41. Stark HJ, Breitkreutz D, Limat A, Bowden P and Fusening NE. (1987). Differentiation, 35, 236-248.
42. Stenn KS, Lawrence L, Veis D, Korsmeyer S and Seiberg M. (1994). J. Invest. Dermatol., 103, 107-111.
43. Veis DJ, Sorenson CM, Shutter JR and Korsmeyer SJ. (1993). Cell, 75, 229-240.
44. Wang Y, Skezely L, Okan I, Klein G and Wiman KG. (1993). Oncogene, 8, 3427-3431.
45. Wingo PA, Tong T and Bolden S. (1995). CA Cancer J. Clin., 45, 8-30.
46. Yang E and Korsmeyer SJ. (1996). Blood, 88, 386-401.
47. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A and Oren M. (1991). Nature, 352, 345-347.
48. Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, Kimmelman J, Remington L, Jacks T and Brash DE. (1994). Nature, 372, 773-776.
49. Zinkel S and Fuchs E. (1994). Semin. Cancer Biol., 5, 77-90.